VASH1 and epilepsy: Based on the expression level of VASH1, we analyzed the clinicopathological parameters and prognostic factors in 83 LGG patients in our hospital, and we found that VASH1 expression was not significantly compared with the age, sex, pathological type, tumor size, site, epilepsy, and KPS scores of LGG patients.